Literature DB >> 23467788

Astigmatism correction with toric intraocular lenses: wavefront aberrometry and quality of life.

Rita Mencucci1, Cristina Giordano, Eleonora Favuzza, Jean-Jacques Gicquel, Leopoldo Spadea, Ugo Menchini.   

Abstract

BACKGROUND/AIM: To evaluate wavefront aberrations and subjective quality of life after toric intraocular lens (TIOL) implantation.
METHODS: Three groups of subjects who underwent unilateral cataract surgery with intraocular lens (IOL) implantation were compared: (1) toric group (n=40): corneal astigmatism >1.50 D, implanted with Acrysof toric SN60TT IOL (Alcon Inc, Fort Worth,  Texas, USA); (2) astigmatic SN60AT group (n=40): corneal astigmatism >1.50 D, implanted with Acrysof SN60AT IOL; and (3) control group (n=40): corneal astigmatism <1.00 D, implanted with Acrysof SN60AT IOL. Uncorrected distance visual acuity (UDVA), refraction, lower order astigmatism (Z(2)2, Z(-2)2), Strehl ratio and the modulation transfer function area ratio were evaluated over a 3 month follow-up period. A standardised quality of life test (National Eye Institute Refractive Error Quality of Life Instrument-42) was distributed to both astigmatic groups 3 months postoperatively.
RESULTS: Postoperative UDVA and aberrometric values were significantly better (p<0.001) and mean postoperative spherical equivalent was significantly lower (p<0.05) in the toric and control groups compared with the astigmatic SN60AT group. The toric group had significantly better postoperative quality of life compared with the astigmatic SN60AT group (p<0.05).
CONCLUSIONS: Acrysof TIOL implantation resulted in better visual, refractive and aberrometric results than SN60AT spherical IOL implantation in astigmatic patients, similar to the control group. The better objective optical and retinal image quality resulted in better subjective quality of life after TIOL implantation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23467788     DOI: 10.1136/bjophthalmol-2013-303094

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  In vitro optical quality of monofocal aspheric toric intraocular lenses: effect of cylindrical power.

Authors:  Teresa Ferrer-Blasco; Alberto Domínguez-Vicent; Santiago García-Lázaro; María Amparo Diez; José F Alfonso; José J Esteve-Taboada
Journal:  Int Ophthalmol       Date:  2017-04-25       Impact factor: 2.031

2.  Effect of two different preoperative calculation schemes on visual outcomes of patients after toric intraocular lens implantation.

Authors:  Xuewen Yu; Jingwen Wang; Xueqi Lin; Dejian Xu; Shuang Ni; Siting Sheng; Wen Xu
Journal:  Int Ophthalmol       Date:  2022-08-06       Impact factor: 2.029

3.  Real-world incidence of monofocal toric intraocular lens repositioning: analysis of the American Academy of Ophthalmology IRIS Registry.

Authors:  Brent A Kramer; John Berdahl; Xiaolin Gu; Mohinder Merchea
Journal:  J Cataract Refract Surg       Date:  2022-03-01       Impact factor: 3.528

4.  Clinical outcomes, predictability and rotational stability following implantation of Eyecryl toric versus TECNIS toric intraocular lenses-A comparative study.

Authors:  Sheetal Brar; Dishitha P Rathod; R P Nikhil; Sri Ganesh
Journal:  Int Ophthalmol       Date:  2021-07-22       Impact factor: 2.031

Review 5.  Global prevalence and economic and humanistic burden of astigmatism in cataract patients: a systematic literature review.

Authors:  David F Anderson; Mukesh Dhariwal; Christine Bouchet; Michael S Keith
Journal:  Clin Ophthalmol       Date:  2018-03-06

6.  Visual outcomes and optical quality after implantation of a diffractive multifocal toric intraocular lens.

Authors:  Xiangfei Chen; Ming Zhao; Yuhua Shi; Liping Yang; Yan Lu; Zhenping Huang
Journal:  Indian J Ophthalmol       Date:  2016-04       Impact factor: 1.848

7.  Comparative evaluation of two toric intraocular lenses for correcting astigmatism in patients undergoing phacoemulsification.

Authors:  Sheetal A Seth; Rakesh K Bansal; Parul Ichhpujani; Natasha G Seth
Journal:  Indian J Ophthalmol       Date:  2018-10       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.